Explore a comprehensive range of Brinzolamide impurities and reference standards essential for pharmaceutical research.
Brinzolamide is a carbonic anhydrase inhibitor used in ophthalmic formulations to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by decreasing aqueous humor production. This helps to protect against optic nerve damage and vision loss.
These compounds support various stages of drug development. This includes product formulation, Abbreviated New Drug Application (ANDA), Drug Master Files (DMFs) submissions, and manufacturing. They are critical for conducting quality assessments, stability studies, and genotoxicity evaluations of Brinzolamide and its related products.
SynThink is a trusted provider of high-quality Brinzolamide impurities, including: Degradation impurities; Genotoxic impurities; Process-related impurities; EP / USP-compliant reference standards and Nitrosamine impurities.
We rigorously characterize and re-test the compounds at regular intervals to ensure consistency and compliance. We supply each product with a detailed Certificate of Analysis (CoA) and comprehensive analytical data, meeting global regulatory standards.
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
